Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?

@article{Rana2010ShouldWC,
  title={Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?},
  author={Jamal S Rana and Sm. Boekholdt},
  journal={Current opinion in cardiology},
  year={2010},
  volume={25 6},
  pages={
          622-6
        }
}
PURPOSE OF REVIEW Despite aggressive low-density lipoprotein cholesterol lowering, patients continue to be at significant risk of cardiovascular events. Assessment of non-high-density lipoprotein cholesterol (non-HDL-C) provides a measure of cholesterol contained in all atherogenic particles. In the third Adult Treatment Panel guidelines, non-HDL-C was introduced as a secondary target of therapy. RECENT FINDINGS A combined post-hoc analysis of data from two prospective, randomized trials… CONTINUE READING
BETA

Figures and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 16 REFERENCES

Efficacy of cholesterol - lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins : a metaana - lysis

  • T Pischon, CJ Girman, FM Sacks
  • Lancet
  • 2008

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women

  • J Liu, CT Sempos, RP Donahue
  • JAMA
  • 2007

Efficacy and safety of cholesterol - lowering treatment : prospective meta - analysis of data from 90 056 participants in 14 randomised trials of statins

  • PM Kearney, PM Blackwell, R Collins
  • Lancet
  • 2005

Similar Papers

Loading similar papers…